## UPS: United Parcel Service, Inc. - XLI: Industrials

### Executive Summary

No thesis match: PEG 1.33 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($96.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Cold Chain Market to Hit US$ 919.9 Billion by 2032 as Key Players**
- Source: openPR.com | 20251211T110857 | Bullish | Relevance: 86%
-  The global cold chain market is projected to reach US$919.9 billion by 2032, growing at a CAGR of 13.8% from US$372.2 billion in 2025. This expansion is driven by increasing demand for perishable goods and pharmaceuticals, stringent regulations, and advancements in technology like IoT-enabled monitoring and automated storage. North America currently dominates the market, while Asia-Pacific is anticipated to be the fastest-growing region.

**2. FedEx (FDX/NYSE): Navigating a Transformative Era in Global Logistics**
- Source: Markets Financial Content | 20251211T160825 | Neutral | Relevance: 71%
- FedEx (FDX/NYSE) is undergoing a significant transformation with its "DRIVE" program and "Network 2.0" initiatives focused on cost reduction and operational efficiencies. The company, a global leader in logistics, is also planning to spin off FedEx Freight into a separate publicly traded entity by June 2026 to unlock shareholder value. Despite a mixed stock performance in the short term, FedEx shows long-term growth potential and is adapting to industry trends through technology investments and sustainability goals, while facing fierce competition and macroeconomic uncertainties.

**3. Should You Buy, Sell or Hold FedEx Stock Before Q2 Earnings?**
- Source: Finviz | 20251211T151003 | Neutral | Relevance: 64%
-  FedEx Corporation (FDX) is poised to release its fiscal Q2 2026 earnings, with analysts anticipating increased earnings per share and revenues fueled by strong holiday shipping demand and cost-reduction initiatives under the DRIVE program. The company has a Zacks Rank #2 and a positive Earnings ESP of +1.38%, suggesting a high probability of beating estimates. FDX stock has outperformed both its industry and rival UPS in the fiscal second quarter and appears undervalued based on its forward 12-month Price/Sales.

**4. Evercore ISI Adjusts Price Target on FedEx to $275 From $239, Maintains In Line Rating**
- Source: marketscreener.com | 20251209T114242 | Neutral | Relevance: 64%
-  Evercore ISI has raised its price target for FedEx (FDX) to $275 from $239, while maintaining an "In Line" rating for the company. This adjustment reflects an updated outlook on the shipping giant's valuation by the Evercore ISI analyst team. The new price target is slightly below the current average target price of $275.14 among analysts.

**5. |TrueBlue Appoints Two New Independent Directors**
- Source: Business Wire | 20251211T170926 | Somewhat-Bullish | Relevance: 62%
-  |TrueBlue, Inc. announced the appointment of William Greenblatt and William Seward as independent directors to its Board, effective January 5, 2026. These appointments followed an extensive search and shareholder input, aiming to strengthen operational oversight and accelerate growth. Both new directors bring extensive experience in their respective fields, with Mr. Greenblatt being a pioneer in background screening and Mr. Seward a seasoned global executive in logistics and supply chain.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+0.6%)
- Blackrock Inc.: 6.5% (-3.9%)
- State Street Corpora: 4.2% (+0.9%)
- Charles Schwab Inves: 3.6% (+1.9%)
- FMR, LLC: 2.8% (+25.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +5.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.33 suggests fair value with growth premium. Forward P/E 14.0x stretched relative to 4% growth. Quality metrics strong (ROE 34%). Balance sheet: $1.5B free cash flow. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $85.2B |
| Beta | 1.09 |
| 52W Range | $82.00 - $136.99 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.33 |
| Forward P/E | 14.0 |
| Current P/E | 14.6 |
| YoY Growth | 4.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.1% to 3.5% (+5.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 74th percentile. MRS_5 at 3.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.47% (CS: 75) | Strong |
| RSI_14 | 65.7 | Neutral |
| MACD Histogram | 0.31 | Bullish |
| vs SMA20 | 1.053x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.044x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $100.48
- **Stop Loss:** $96.04 (4.4% risk)
- **Target:** $104.92 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 310
- **Position Value:** $31,148.80
- **Portfolio %:** 31.15%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-27 (Est: $2.18)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.74 | +33.9% |
| 2025Q2 | $1.57 | $1.55 | -1.0% |
| 2025Q1 | $1.38 | $1.49 | +7.9% |
| 2024Q4 | $2.53 | $2.75 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*